Interventions that were shown to extend human longevity in Randomized Clinical Trials (RCTs)
(This is my relatively unbiased reading of scientific literature. What has worked the best in clinical trials so far?)
Weight loss
- [Association] Optimal BMI that minimizes the risk of all cause mortality is between 20-24 (ref).
- [RCT] Lifestyle interventions: 15% reduction in all cause mortality after 5.5 kg avg. weight loss (ref).
- [Association] Bariatric surgery: 38%-41% reduction in all cause mortality (ref, ref) after 10%-27% avg. weight loss (ref, ref, ref).
- [RCT] Anti-diabetic drugs: Tirzepatide 22.5% (ref), Semaglutide 17% (ref), Acarbose 3%-7.5% (ref, ref, ref), Metformin 5.6% (ref) weight loss.
- Once you become obese, permanent weight loss through diet and exercise is very unlikely (2019). Metformin, Acarbose, SLT2-i are very helpful for small weight loss. For big permanent weight loss, GLP1-RA class of drugs and surgery are very effective.
LDL Lowering Meds / Statin
- [RCT, Association] Optimal LDL-C appears to be as low as possible, ideally maintained at low levels starting from an as early age as possible. Aggressively lowering LDL-C < 70 mg/dL can stop progression of atherosclerotic plaques and may even cause some plaque regression (ref, ref, ref).
- [RCT] 8%-13% reduction in all cause mortality in primary prevention (ref, ref) – assuming you have dyslipidemia.
- [Mice] +4.1% increase in avg. lifespan (ITP, not statistically significant). +9% increase in lifespan when a statin is combined with ACE inhibitor (ref).
- [Association] Associated with improved cancer outcomes across many cancer types (ref, ref).
BP Meds / ACE inhibitor
- [RCT] Intensive BP lowering therapy (SBP <120 mm Hg) resulted in +2.9 years additional lifespan compared to the standard BP lowering (SBP <140 mm Hg). The intensive arm demonstrated improved brain health (ref, ref).
- [RCT] 10% reduction in all cause mortality from using ACE inhibitors (ref) – assuming you have high BP.
- [Mice] +5% increase in avg. lifespan from Captopril (ITP). +2.3% increase in avg. lifespan from Enalapril (ITP, not statistically significant). +9% increase in lifespan when combined with Statin (ref).
- [Association] Associated with improved cancer outcomes across many cancer types (ref).
Combination therapy (~ Statin + BP Meds + Aspirin)
- [RCT] 20% reduction in all cause mortality from aspirin + statin + BP meds (ref).
- [RCT] 34% reduction in major adverse cardiovascular events (MACE) from aspirin + statin + BP meds (ref31791-X/fulltext)).
- [RCT] 24% reduction in CV death/MI/stroke from statin + BP meds (ref).
Testosterone Replacement Therapy (TRT)
- [RCT] (53%, 61%, 79%) reduction in all cause mortality for the normal weight, overweight, obese males respectively (ref) – assuming you have low testosterone.
- It should to be mentioned that starting TRT might be risky or even harmful if you have established CVD.
- [Association] 47%-56% reduction in all cause mortality (ref).
Flu vaccine
Paper · npj Vaccines · 2021Vaccination as a preventative measure contributing to immune fitnessThe primary goal of vaccination is the prevention of pathogen-specific infection. The indirect consequences may include maintenance of homeostasis through prevention of infection-induced complications; trained immunity that re-programs innate cells to respond more efficiently to later, unrelated threats; slowing or reversing immune senescence by altering the epigenetic clock, and leveraging the pool of memory B and…nature.com- [RCT] 11%-42% reduction in all cause mortality in RCTs and prospective cohort studies (ref, ref, ref).
- [Association] 43% reduction in all cause mortality, which was a very consistent finding across 40+ studies (ref, ref).
- [Association] All cause mortality was reduced in adults with diabetes (ref), hypertension (ref), cardiovascular disease (ref), cancer (ref).
- [Association] Lowered Alzheimer's risk by 25-40% (ref, ref).
Multivitamin
- [RCT] Trend towards 6% reduction in all-cause mortality across primary prevention trials (RR: 0.94; 95% CI: 0.89, 1.00) (ref).
- [RCT] Taking a basic RDA level multivitamin (Centrum Silver) for 3 years slowed cognitive decline in healthy older adults by 60% (ref).
- [RCT] 8% reduction in cancer risk from a basic RDA level multivitamin (ref).
Vitamin D3
- [RCT] Trend towards 5% reduction in all cause mortality HR=0.95 (0.91 to 1.00, p=0.07). 15% reduced risk of cancer mortality HR=0.85 (0.74 to 0.97). (ref)
Fish Oil (EPA)
- [RCT] Trend towards 3% reduced all-cause mortality (RR = 0.97, 95% CI = 0.94–1.01). 7%-8% reduced risk of CVD mortality (RR = 0.92, 95% CI = 0.87–0.98). More significant mortality reduction with higher dose and EPA-rich omega-3. (ref, ref00277-7/fulltext))
- [RCT] 20% reduction in HS-CRP (ref), significantly reduced depression (ref, ref).
- [Association] 13%-18% lower all cause mortality (ref, ref%20for%20incident%20CVD%20events.)).
- [Mice] No effect on mice lifespan (ITP).
Caveat: Significant variability exists from individual to individual. Working for the population doesn’t mean a specific treatment will work for you. That’s why you need to make treatment decisions based on your individual lab values & response. Always work with a Dr, ideally a cardiologist when it comes to CVD.
See this blog post for Level 2 and Level 3 interventions:


